CTSO
Cytosorbents Corp
NASDAQ · Healthcare · Medical - Devices · US
$5.75
−0.17%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.90
- Revenue estimate
- $9.9M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.07
- EPS estimate
- -$0.04
- Revenue actual
- $9.6M
- Revenue estimate
- $9.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -38.8%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.04 | -$0.07 | Miss -75.00% | $9.6M |
| May 13, 2026 | -$0.06 | -$0.08 | Miss -33.33% | $8.9M |
| Mar 25, 2026 | -$0.05 | -$0.09 | Miss -80.00% | $9.2M |
| Nov 13, 2025 | -$0.06 | -$0.04 | Beat 33.33% | $9.5M |
| Aug 7, 2025 | -$0.07 | -$0.05 | Beat 28.57% | $9.6M |
| May 14, 2025 | -$0.08 | -$0.06 | Beat 25.00% | $8.7M |
| Mar 31, 2025 | -$0.07 | -$0.03 | Beat 57.14% | $6.5M |
| Nov 7, 2024 | -$0.07 | -$0.08 | Miss -14.29% | $8.6M |
| May 9, 2024 | -$0.12 | -$0.12 | In line | $9.8M |
| Mar 14, 2024 | -$0.14 | -$0.12 | Beat 14.29% | $8.7M |
| Nov 9, 2023 | -$0.12 | -$0.21 | Miss -75.00% | $7.8M |
| May 2, 2023 | -$0.13 | -$0.17 | Miss -30.77% | $7.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026